BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Clofibrate
,
rs4950928
,
VEGFA
,
Angiogenesis
,
Ischemia
,
Intestine
,
Laryngoscope
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Ln229
Summary
General Info
Curated Studies
Most Correlated Studies
Glioma LN229 cells with induced CYR61 expression
Glioblastoma LN229 cells treated with UM-164
Glioblastoma multiforme LN229 cells with survivin (BIRC5) NES mutant treated with Temozolomide
Glioblastoma multiforme LN229 cells treated with anti-tumorigenic agent ursodeoxycholic acid
Glioblastoma LN229 cells overexpressing EGFRvIII in the presence or absence of TRIM24 shRNA
Explore Curated Studies Results
Literature
Most Relevant Literature
Antineoplastic effects of cassava-cyanide extract on human glioblastoma (LN229) cells.
Tetra-O-methyl-nordihydroguaiaretic acid inhibits energy metabolism and synergistically induces anti…
Quantitative proteomic analysis of GnRH agonist treated GBM cell line LN229 revealed regulatory prot…
Phenformin and metformin inhibit growth and migration of LN229 glioma cells in vitro and in vivo.
Extracellular Proton Concentrations Impacts LN229 Glioblastoma Tumor Cell Fate via Differential Modu…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for Ln229
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ